Cancer Genetics and Epigenetics 2024, Vol.12, No.4, 166-181 http://medscipublisher.com/index.php/cge 176 data sharing practices must comply with stringent privacy laws to prevent unauthorized access and misuse of genetic data (Hammer, 2019). Ensuring informed consent is critical, where patients must be fully aware of how their genetic information will be used, stored, and shared (Hammer, 2019). 8.3 Social implications and public perception The social implications of genetic testing for breast cancer are profound, affecting patients' social identity and relationships. Knowledge of a genetic predisposition can alter how individuals perceive themselves and how they are perceived by others. For some, this information can lead to a sense of stigma or social isolation, particularly in communities where there is limited understanding or acceptance of genetic conditions (Tamimi et al., 2023). Fear of social stigma can also deter individuals from undergoing genetic testing, even when it could provide significant health benefits (Tamimi et al., 2023). Moreover, genetic information can impact family dynamics. The knowledge that one carries a hereditary risk for breast cancer can lead to complex emotional responses within families, including guilt, anxiety, and changes in familial roles and responsibilities (Surbone, 2001; Neves et al., 2022). For instance, individuals may feel a moral obligation to inform relatives about potential risks, which can strain relationships, especially if family members react negatively or with denial (Neves et al., 2022). Public perception of genetic testing is also influenced by broader societal attitudes towards genetics and disease. There is a need for public education to improve understanding and acceptance of genetic testing, which can help mitigate fears and misconceptions. Effective communication strategies are essential to convey the benefits and limitations of genetic testing, ensuring that individuals can make informed decisions without undue influence from societal pressures (Thapa et al., 2020). In conclusion, the ethical, legal, and social implications of genetic research in breast cancer are multifaceted and require careful consideration. Addressing these issues involves balancing the benefits of genetic knowledge with the potential risks and ensuring that individuals are supported throughout the testing process. Legal protections against discrimination and robust privacy measures are essential to safeguard individuals' rights, while public education and support can help mitigate the social impacts of genetic information. 9 Future Directions in Genetic Research on Breast Cancer 9.1 Emerging genetic targets and therapies The identification of new genetic targets for therapy and prevention is a rapidly evolving area in breast cancer research. Recent advances in whole exome sequencing and multigene panels have enabled the discovery of numerous genetic mutations associated with breast cancer, which can be targeted for therapeutic intervention. For instance, mutations in BRCA1/2, PIK3CA, and other genes have been identified as significant contributors to breast cancer pathogenesis, and targeting these mutations has shown promise in clinical trials (Lima et al., 2019; Hong and Xu, 2022). Additionally, genome-wide association studies (GWAS) have identified over 150 common genetic loci associated with breast cancer risk, providing a rich source of potential targets for new therapies (Guo et al., 2018). Targeted therapies, such as poly(ADP-ribose) polymerase (PARP) inhibitors for BRCA1/2 deficient tumors, have already transformed the treatment landscape for certain breast cancer subtypes (Campeau et al., 2008). Moreover, the role of epigenetic modifiers in breast cancer pathogenesis is gaining attention, with enzymes that modify histone proteins emerging as potential therapeutic targets (Lee et al., 2023). These findings underscore the importance of continuing to explore genetic and epigenetic alterations in breast cancer to develop more effective and personalized treatment strategies. 9.2 Challenges and opportunities Despite significant progress, several challenges remain in the field of genetic research on breast cancer. One major challenge is the heterogeneity of breast cancer, which complicates the identification of universally effective genetic targets (Baliu-Piqué et al., 2020). Tumor heterogeneity, driven by both genetic and non-genetic factors,
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==